Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Paul S. who wrote (315)	3/30/1998 10:22:00 AM
From: David Culver	Read Replies (1) \| Respond to of 1185

Just to let you know the Mini Cap Analysis focuses more on resource stocks. I had some major losses with this newsletter. Like all news letters they forget the bad ones and play up the good recommendations. But decide for yourself. Dave Culver

To: Paul S. who wrote (315)	3/30/1998 10:42:00 AM
From: Wisee	Respond to of 1185

Paul, To subscribe to Maedel's Mini-Cap Analyst call (604)669-8270. Their website is www.maedels.com. Hopefully this helps. Lately, Maedel has not had any big winners, but who has??? Wisee

To: Paul S. who wrote (315)	3/30/1998 10:47:00 AM
From: Casey	Read Replies (1) \| Respond to of 1185

Paul: <<Did Maedels not recommend NRT at around the $.90 level. It seems that they know what they are doing and I've heard very good tings about them. Does anyone have information on how to subscribe to Maedels? Do they have a website?>> Maedel's recommended NRT @ .97 but his buy instruction was to buy up to $1.80 since his instruction came out the day the stock price spiked. He said NRT should quickly go to $3.20. It quicly tanked, and is only now recovering. I have had nothing but very bad experiences with Maedels's picks. His record over the last 18 months is disastrous - and that is being kind.